|
1
|
Tien AC, Rajan A and Bellen HJ: A Notch
updated. J Cell Biol. 184:621–629. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kureishy N, Sapountzi V, Prag S, Anilkumar
N and Adams JC: Fascins, and their roles in cell structure and
function. BioEssays. 24:350–361. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang C, Qi R, Li N, Wang Z, An H, Zhang Q,
Yu Y and Cao X: Notch1 signaling sensitizes tumor necrosis
factor-related apoptosis-inducing ligand-induced apoptosis in human
hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53
degradation and up-regulating p53-dependent DR5 expression. J Biol
Chem. 284:16183–16190. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang XQ, Zhang W, Lui EL, Zhu Y, Lu P, Yu
X, Sun J, Yang S, Poon RT and Fan ST: Notch1-Snail1-E-cadherin
pathway in metastatic hepatocellular carcinoma. Int J Cancer.
131:E163–E172. 2012. View Article : Google Scholar
|
|
5
|
Villanueva A, Alsinet C, Yanger K, Hoshida
Y, Zong Y, Toffanin S, Rodriguez-Carunchio L, Solé M, Thung S,
Stanger BZ, et al: Notch signaling is activated in human
hepatocellular carcinoma and induces tumor formation in mice.
Gastroenterology. 143:1660–1669.e7. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Geisler F, Nagl F, Mazur PK, Lee M,
Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM and Siveke JT:
Liver-specific inactivation of Notch2, but not Notch1, compromises
intrahepatic bile duct development in mice. Hepatology. 48:607–616.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gao J, Song Z, Chen Y, Xia L, Wang J, Fan
R, Du R, Zhang F, Hong L, Song J, et al: Deregulated expression of
Notch receptors in human hepatocellular carcinoma. Dig Liver Dis.
40:114–121. 2008. View Article : Google Scholar
|
|
8
|
Yamasaki K, Hayashi Y, Okamoto S, Osanai M
and Lee GH: Insulin-independent promotion of chemically induced
hepatocellular tumor development in genetically diabetic mice.
Cancer Sci. 101:65–72. 2010. View Article : Google Scholar
|
|
9
|
Edge S, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer; New York: 2010
|
|
10
|
Liver Cancer Study Group of Japan: The
Clinical and Pathological Study of Primary Liver Cancer. 5th
edition. Kanehara Press; Tokyo: 2008
|
|
11
|
Mizushima S and Nagata S: pEF-BOS, a
powerful mammalian expression vector. Nucleic Acids Res.
18:53221990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kato H, Sakai T, Tamura K, Minoguchi S,
Shirayoshi Y, Hamada Y, Tsujimoto Y and Honjo T: Functional
conservation of mouse Notch receptor family members. FEBS Lett.
395:221–224. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hayashi Y, Osanai M and Lee GH: Fascin-1
expression correlates with repression of E-cadherin expression in
hepatocellular carcinoma cells and augments their invasiveness in
combination with matrix metalloproteinases. Cancer Sci.
102:1228–1235. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Theise N, Chua M and Reid LM: The
stem cell niche of human livers: Symmetry between development and
regeneration. Hepatology. 48:1598–1607. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Litten JB, Chen TT, Schultz R, Herman K,
Comstock J, Schiffman J, Tomlinson GE and Rakheja D: Activated
NOTCH2 is overexpressed in hepatoblastomas: An immunohistochemical
study. Pediatr Dev Pathol. 14:378–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dill MT, Tornillo L, Fritzius T,
Terracciano L, Semela D, Bettler B, Heim MH and Tchorz JS:
Constitutive Notch2 signaling induces hepatic tumors in mice.
Hepatology. 57:1607–1619. 2013. View Article : Google Scholar
|
|
17
|
Zhou L, Wang DS, Li QJ, Sun W, Zhang Y and
Dou KF: The down-regulation of Notch1 inhibits the invasion and
migration of hepatocellular carcinoma cells by inactivating the
cyclo-oxygenase-2/Snail/E-cadherin pathway in vitro. Dig Dis Sci.
58:1016–1025. 2013. View Article : Google Scholar
|
|
18
|
Zhou L, Zhang N, Song W, You N, Li Q, Sun
W, Zhang Y, Wang D and Dou K: The significance of Notch1 compared
with Notch3 in high metastasis and poor overall survival in
hepatocellular carcinoma. PLoS One. 8:e573822013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ng IO, Ng MM, Lai EC and Fan ST: Better
survival in female patients with hepatocellular carcinoma. Possible
causes from a pathologic approach. Cancer. 75:18–22. 1995.
View Article : Google Scholar : PubMed/NCBI
|
